English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Results 14 J-SLE female patients were included, with disease onset between 6 and 16 years of age (mean 11,9 years), and mean disease duration of 6,5 years (2-15 years). Five patients had systemic hypertension (4 of them with renal disease), none smoked. 3 patients were overweight (1 with dysplidemia), 11 had normal weight. Total cholesterol>200 mg/dL in 3 patients, low-density lipoprotein cholesterol>130 mg/dL in 3 patients, triglycerides>150 mg/dL in 2 patients, high-density lipoprotein cholesterol 100 mg/dL. Statins were used in 2 patients, angiotensin converting enzyme inhibitors in 5 and aspirin in 4. Non-pharmacologic risk factor management was advised in all cases. There were no overt clinical manifestations of atherosclerotic disease. 2 patients presented with thrombosis (both with antiphospholipid antibodies).

Traditional cardiovascular risk factors in a cohort of juvenile-onset systemic lupus erythematosus (J-SLE)